Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families - 29/08/11
, KRISTINA SECNIK, PH.D., MARYNA MARYNCHENKO, B.A., PAUL GREENBERG, M.S., AMI CLAXTON, PH.D.ABSTRACT |
Objective |
To estimate the direct (medical and prescription drug) and indirect (work loss) costs of children treated for attention-deficit/hyperactivity disorder (ADHD) and their family members.
Method |
The data source was an administrative database from a national, Fortune 100 manufacturer that included all medical, pharmaceutical, and disability claims for beneficiaries (n > 100,000). The analysis involved four samples. The ADHD patient sample included individuals age 18 or younger with at least one ADHD claim during the study period (1996–1998). Resource utilization of ADHD patients was contrasted with a matched control sample of patients who did not have claims for ADHD. The ADHD and non-ADHD family samples included non-ADHD family members of ADHD patients and their matched controls.
Results |
The annual average expenditure (direct cost) per ADHD patient was $1,574, compared to $541 among matched controls. The annual average payment (direct plus indirect cost) per family member was $2,728 for non-ADHD family members of ADHD patients versus $1,440 for family members of matched controls. Both patient and family cost differences were significant at the 95% confidence level.
Conclusions |
ADHD imposes a significant financial burden regarding the cost of medical care and work loss for patients and family members.
Le texte complet de cet article est disponible en PDF.Key Words : attention-deficit/hyperactivity disorder, direct costs, indirect costs, family burden
Plan
| Research supported by an unconditional grant from Eli Lilly and Company. |
|
| Portions of this manuscript were presented at the 48th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 2001. |
Vol 42 - N° 12
P. 1415-1423 - décembre 2003 Retour au numéro
Article précédent
- Parental Perception of Problems and Mental Health Service Use for Hyperactivity
- KAPIL SAYAL, ERIC TAYLOR, JENNIFER BEECHAM
- Psychopathology and Substance Abuse in Parents of Young Children With Attention-Deficit/Hyperactivity Disorder
- ANDREA M. CHRONIS, BENJAMIN B. LAHEY, WILLIAM E. PELHAM, HEIDI L. KIPP, BARBARA L. BAUMANN, STEVE S. LEE
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?